Patents
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
03/2001
03/07/2001CN1062859C Substd 1-naphthoyl guanidines, their preparing method, use and drug contg. them
03/06/2001USRE37087 Insecticidal triffluormethyl alkane derivatives
03/06/2001US6197993 Prostaglandin e2 antagonists or agonists
03/06/2001US6197953 Process for preparing optically active trans-3-substituted glycidic acid ester
03/06/2001US6197798 Inhibitors of microsomal triglyceride transfer protein
03/06/2001US6197791 N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
03/06/2001US6197770 Alkenyl- and alkynl-containing metalloprotease inhibitors
03/06/2001CA2317296A1 Process for the preparation of polythiopolycarboxylic acids
03/01/2001WO2001014316A1 Substituted chiral allosteric hemoglobin modifiers
03/01/2001WO2001014310A1 PLEUROMUTILIN β-KETOESTERS
03/01/2001CA2384511A1 Substituted chiral allosteric hemoglobin modifiers
02/2001
02/28/2001EP1078917A1 Amidino derivatives and drugs containing the same as the active ingredient
02/28/2001EP1077955A1 Method for producing isoxazoline-3-yl-acyl benzene
02/28/2001EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/28/2001EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/28/2001EP1077911A1 Method for orthometalation of a carbocyclic aromatic derivative bearing at least an electron donor group
02/28/2001CN1285820A Metabotropic glutamate receptor antagonists for treating central nervous system disease
02/28/2001CN1062554C Substituted guanidine cinnamate, its prepn., its application as medicine or diagnosing agent and medicine containing the compound
02/27/2001US6194603 Polyisocyanate compound, process for producing the same and optical materials using the same
02/27/2001US6194589 Production of amide derivatives and intermediate compounds therefor
02/27/2001US6194467 Diabetes remedies
02/22/2001WO2001012595A1 Process for producing aromatic disulfides
02/22/2001WO2001012587A1 Aminosalicylclic acid amides and their use for combating organisms that are harmful to plants
02/22/2001WO2000071514A8 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
02/22/2001WO2000071500A8 Halogen compounds
02/22/2001WO2000055126A3 N-cyanomethylamides as protease inhibitors
02/22/2001WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
02/22/2001DE19938737A1 Aminosalicylsäureamide Aminosalicylamides
02/21/2001EP1076641A1 Inhibitors of impdh enzyme
02/21/2001EP0809628B1 Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups based on dicarboxylic acid diamides
02/21/2001CN1284500A Theodicarb producing equipment
02/21/2001CN1062265C Method for producing triazine derivatives
02/21/2001CN1062262C Substituted vinylurea derivatives and medicine containing the same
02/20/2001US6191157 Anticholesterol agents; cardiovascular disorders
02/20/2001CA2191789C Biaromatic compounds containing an adamantyl group in ortho position; pharmaceutical and cosmetic compositions containing them and use thereof
02/20/2001CA2005283C Radiation-sensitive, ethylenically unsaturated, copolymerizable compounds and their preparation
02/15/2001WO2001010825A1 Carbamate derivatives and agricultural/horticultural bactericides
02/15/2001WO2001010776A1 Reductive combustion of ammonium salts of sulfuric acid
02/14/2001EP1076053A1 3-arylphenyl sulfide derivatives and insecticides and miticides
02/14/2001EP1075465A1 Arylphenyl-substituted cyclic keto enols
02/14/2001EP1075260A2 Novel fatty acid analogues for the treatment of primary and secondary restenosis
02/14/2001EP1075259A1 Novel fatty analogues for the treatment of diabetes
02/14/2001EP1075258A1 Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
02/14/2001EP0777511B1 Fluorochemical foam stabilizers and film formers
02/14/2001CN1284057A Adamantane derivatives
02/14/2001CN1283614A Sulfur-bearing unsaturated carboxylic ester compound and use thereof
02/14/2001CN1283447A Locally-used weight reducing face-care compsns.
02/13/2001US6187963 Processes for the manufacture of acrolein derivatives
02/13/2001US6187958 Amino group-containing thiols and method for production thereof
02/13/2001US6187944 A phenyl acrylonitrile compounds useful as active ingredients of an insecticide, a miticide, a nematicide, a soil pesticide, a fungicide and a marine antifouling agent
02/13/2001US6187933 Bind to retinoid receptors; treating skin disorders
02/13/2001US6187910 Chelation compounds, radionuclide metal chelate compounds and radiolabeled targeting moieties formed therefrom, and methods of making and using these compounds, complexes and conjugates for diagnostic and therapeutic use
02/13/2001CA2147806C Polyenic compounds; pharmaceutical and cosmetic compositions containing them and uses
02/13/2001CA2021501C Topical pharmaceutical compositions
02/08/2001WO2001009221A1 Amine hardener for epoxy resins
02/08/2001WO2001009095A1 Mutilin derivatives and their use as antibacterials
02/08/2001WO2001009088A1 Urea derivatives as inhibitors of ccr-3 receptor
02/08/2001WO2001008672A2 Glucamine compounds for treating hepatitis virus infections
02/08/2001WO2000066528A3 Quinones for treatment of diseases
02/08/2001CA2380296A1 Amine hardener for epoxy resins
02/08/2001CA2362785A1 Glucamine compounds for treating hepatitis virus infections
02/07/2001EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
02/07/2001CN1283180A Inhibition of raf kinase using symmerical and unsymmerical substituted diphenyl ureas
02/07/2001CN1283178A Processes for producing beta-halogenno-alpha, -amino-carboxylic acids and phenylcy steine derivatives and intermediates thereof
02/06/2001US6184414 Extraction of the butyric acid, obtained by the cyanohydrin reaction with methylmercaptopropionaldehyde and acidolysis, with an inert solvent non-miscible or partially miscible with water to separate organic products and ammonium salts; feeds
02/06/2001US6184396 Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient
02/06/2001US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites
02/06/2001US6184249 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
02/06/2001US6184210 Dipeptide-based caspase (proteolytic family of cysteine proteases whose active site cysteine residue is essential for ice-mediated apoptosis) inhibitors of given formula are potent inhibitors of apoptosis
02/06/2001CA2147807C Bicyclic-aromatic compounds; pharmaceutical and cosmetic compositions containing them and uses
02/01/2001WO2001007400A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient
02/01/2001WO2000003743A3 Use of inhibitors of prenyltransferases for inhibiting fungal growth
02/01/2001CA2382757A1 Carboxylic acid derivatives and adhesion molecule inhibitors which contain the same as effective ingredients
01/2001
01/31/2001EP1072591A1 Novel urea derivatives
01/31/2001EP1072590A2 Process for the prevention of hydrogen sulphide and/or mercaptan emission from sulphurised organic compounds
01/31/2001EP1072588A1 Process for producing arylsulfenyl halide
01/31/2001EP1072587A1 Sulfonamide derivatives and drugs containing the same as the active ingredient
01/31/2001EP1071724A2 Oxygen scavenging hydrotalcite and compositions containing same
01/31/2001EP1071660A1 N-sulphonyl and n-sulphinyl phenylglycinamide
01/31/2001CN1282319A Aminobutanoic acid derivatives
01/31/2001CN1282317A Novel P-aminophenol derivatives and use thereof
01/31/2001CN1282316A Substituted cyslopentane and cyclopentene compounds useful as neuraminidase inhibitors
01/30/2001US6180675 IL-8 receptor antagonists
01/30/2001US6180619 Prenyl transferase inhibitors
01/30/2001CA1341173C Fungicides
01/29/2001CA2314578A1 A process for inhibiting the emission of hydrogen sulfide and/or mercaptans from sulfurized organic compounds
01/25/2001WO2001005793A1 1,2,3,4,5,6-HEXAHYDROAZEPINO[4,5-b]INDOLES CONTAINING ARYLSULFONES AT THE 9-POSITION
01/25/2001WO2001005756A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors
01/25/2001WO2001005748A1 Oligomeric amino acid derivatives useful as nitric oxide synthase inhibitors
01/25/2001WO2001005743A1 3-amino-2-benzyl-1-phenyl-propane derivatives
01/25/2001WO2001005742A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
01/25/2001WO2000061527A3 The use of metal dithiolene complexes in selective olefin recovery
01/25/2001WO2000058293A3 Glucokinase activators
01/25/2001WO2000054756A3 Nitrate esters and their use for introducing neuroprotection and cognition enhancement
01/25/2001DE19933421A1 2-Benzyl-3-dimethylamino-1-phenyl-propanderi- vate 2-benzyl-3-dimethylamino-1-phenyl-propanderi- derivatives
01/25/2001CA2379891A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
01/25/2001CA2378723A1 3-amino-2-benzyl-1-phenyl-propane derivatives
01/25/2001CA2377718A1 1,2,3,4,5,6-hexahydroazepino¬4,5-b|indoles containing arylsulfones at the 9-position
01/24/2001EP1070703A1 Cyclobutene derivatives
01/24/2001EP1070046A1 Propanolamine derivatives